Business Description
aTyr Pharma is a San Diego-based clinical-stage biotech company focused on developing treatments for inflammatory and fibrotic diseases. Its most advanced drug candidate, efzofitimod, is currently being studied in multiple clinical trials for pulmonary sarcoidosis and related lung conditions, with a partnership in place with Kyorin Pharmaceutical to bring it to patients in Japan. The company also has several earlier-stage programs targeting fibrosis, liver disease, and aggressive cancers, all rooted in its research into a family of proteins known as tRNA synthetases.
